Evaluation of Personalised Support Program Effectiveness in Sperm Quality Improvement (FabLife)
Evaluation of FabLife's Personalised Support Program Effectiveness in Sperm Quality Improvement in Men Suffering From Hypofertility
Sponsor: FabLife
Listed as NCT03475199, this NA trial focuses on Male Infertility and remains ongoing. Sponsored by FabLife, it has been updated 7 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2021 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Recruiting NA
-
Mar 2019 — Jan 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2018 — Mar 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FabLife
- Keyrus Biopharma
For direct contact, visit the study record on ClinicalTrials.gov .